4523
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Eisai Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of prescription and over-the-counter medicines. The company operates through five reporting segments: Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Russia, Oceania), and East Asia-Global South (Korea, Taiwan, India, ASEAN, Latin America). Key subsidiaries include EA Pharma in Japan, Eisai Corporation of North America and Eisai Inc. in the United States, Eisai Ltd. in Canada, Eisai (China) Investment Co., Ltd. and Eisai (China) Pharmaceutical Co., Ltd. in China, Eisai Europe Ltd. in the United Kingdom, Eisai GmbH in Germany, and Eisai Asia Regional Services Pte. Ltd. in Singapore. The company also conducts licensing, pharmaceutical raw material, and business services operations through Sampuranet Co., Ltd.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Drug Manufacturers - General Homepage eisai.co.jp
Sector Healthcare IR page eisai.co.jp/index.html
Tags
prescription medicines, over-the-counter medicines, pharmaceutical raw materials, licensing, business services, EA Pharma, Eisai Corporation of North America, Eisai Inc., Eisai Ltd., Eisai (China) Investment Co. Ltd., Eisai (China) Pharmaceutical Co. Ltd., Eisai (Suzhou) Trading Co. Ltd., Eisai Europe Ltd., Eisai Manufacturing Ltd., Eisai GmbH, Eisai S.A.S., Eisai Farmacéutica S.A., Eisai S.r.l., Eisai Asia Regional Services Pte. Ltd., Eisai (Thailand) Marketing Co. Ltd., Eisai Korea Inc., Eisai Pharmaceuticals India Pvt. Ltd., Sampuranet Co. Ltd.
Press page eisai.co.jp/news/index.html

Metrics

Valuation  
Market cap ¥ 1.403T
Market cap (USD) $ 8.77B
P/E 30.92
PEG —
P/BV 1.52
P/S 1.57
P/OCF 20.39
P/FCF 51.65
Dividend yield 3.3%
Turnover / mcap —
Returns  
ROE 4.3%
ROI 3.5%
ROIC 3.2%
Profit margin 4.7%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -11.4%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 71
Quality score -38.9%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 825.378B 789.4B 741.751B 744.402B 756.226B 645.942B 695.621B 642.834B 600.054B 539.097B 547.922B 548.465B 600.363B 573.658B
Net profit 38.558B 46.432B 42.406B 55.432B 47.954B 42.119B 121.767B 63.386B 51.845B 39.358B 54.933B 43.254B 32.955B 48.275B
Free cash flow 20.156B 7.148B 31.17B -36.331B 77.123B 35.709B 52.556B 76.092B — — — — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 4.871K 4.145K 6.216K 7.504K 5.67K 7.419K 7.932K 6.213K 6.781K 5.764K 6.771K 8.535K 4.018K 4.201K
Price performance 12m 0.18 -0.33 -0.17 0.32 -0.24 -0.06 0.28 -0.08 0.18 -0.15 -0.21 1.12 -0.04 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) — 151B 157B 180B 160B 208B 187B 217B 220B 227B
↳ YoY growth +3.4% +14.9% -10.9% +29.7% -10.0% +16.0% +1.3% +3.2%
↳ 5y CAGR +4.3% +6.8% +4.1% +7.2%
Borrowings, current (JPY) — 16.4B 49B 35B 40B — 41.2B 24.6B 87.7B 51.3B
Borrowings, non-current (JPY) — 157B 89.9B 54.9B 49.9B 94.9B 84.9B 135B 99.8B 135B
Cash and deposits (JPY) 187B 271B 286B 254B 249B 310B 267B 305B 266B 245B
Intangible assets (JPY) — 107B 98.1B 106B 109B 95.5B 89.2B 85.5B 75.3B 88.1B
Right-of-use assets (JPY) — — — — — 41.6B 33.7B 33.9B 30.8B 30.8B
Net debt (borrowings + leases - cash) (JPY) — -97.4B -148B -164B -159B -215B -141B -145B -78B -59.3B
Cash flow detail
Operating cash flow (JPY) 75.9B 150B 104B 103B 73.9B 118B -1.77B 56B 30.1B 61.3B
Purchases of property, plant and equipment (JPY) — -10.5B -18.2B -15.3B -19.1B -29B -22.6B -14.3B -11.9B -15.4B
Purchases of intangible assets (JPY) — -14.2B -9.45B -35B -19B -11.4B -12B -10.5B -11B -25.8B
Dividends paid (cash effect) (JPY) — -42.9B -43B -45.8B -45.9B -45.9B -45.9B -45.9B -45.5B -45.1B
Share buybacks (cash effect) (JPY) — — — — — — — -21M -30.1B -9M
Interest paid (cash effect) (JPY) — -2.68B -1.42B -1.08B -1.03B -1.29B -1.48B -1.56B -2.55B -3.99B
Income taxes paid (cash effect) (JPY) — -15.3B -18.3B -20B -17.9B -10.6B -22.6B -12.7B -20.2B -16.7B
Free cash flow (OCF - PPE - intangibles) (JPY) — 125B 76.1B 52.6B 35.7B 77.1B -36.3B 31.2B 7.15B 20.2B
Income detail
Research and development expense (JPY) — 140B 145B 140B 150B 172B 173B 169B 172B 159B
↳ 5y CAGR +4.4% +3.1% +4.1% +1.1%
Total comprehensive income (JPY) 36.8B 53.8B 79.5B 96.2B 71B 90.8B 96.9B 123B 43.2B 105B
Comprehensive income to owners (JPY) — 51.2B 76.4B 95.5B 70.6B 93B 95.5B 121B 41.5B 103B
Segments
Americas · Segment revenue (JPY) — 114B 97.9B 128B 143B 172B 213B 232B 278B 300B
↳ YoY growth -14.1% +30.7% +11.6% +20.5% +23.7% +9.2% +19.7% +8.0%
Americas · Segment operating income (JPY) — 43.6B 46.3B 60B 64.7B 79.2B 133B 147B 158B 174B
Asia And Latin America · Segment revenue (JPY) — 42.6B 48.7B 46.6B 45.9B 50.6B 49.8B 54.2B — —
↳ YoY growth +14.3% -4.3% -1.6% +10.3% -1.6% +8.8%
Asia And Latin America · Segment operating income (JPY) — 12.4B 15.3B 16B 18.6B 20.8B 22.1B 24B — —
China · Segment revenue (JPY) — 56.2B 66.3B 77B 85.1B 106B 111B 112B 116B 131B
↳ YoY growth +17.9% +16.1% +10.5% +25.1% +4.1% +1.0% +3.2% +13.2%
China · Segment operating income (JPY) — 15.5B 24.4B 32.8B 40.4B 55.4B 55.6B 57.7B 57.2B 59.3B
EMEA · Segment revenue (JPY) — 44.3B 49.8B 53.7B 55.2B 59.3B 72.2B 76B 79.4B 81.5B
↳ YoY growth +12.4% +7.7% +3.0% +7.4% +21.6% +5.3% +4.5% +2.7%
EMEA · Segment operating income (JPY) — 15.4B 19.7B 23B 25.7B 40.9B 41.6B 42B 35.9B 30.4B
East Asia Global South · Segment revenue (JPY) — — — — — — — 54.2B 59.6B 68.8B
↳ YoY growth +9.8% +15.6%
East Asia Global South · Segment operating income (JPY) — — — — — — — 22.8B 27.4B 30.2B
Japan · Segment revenue (JPY) — 296B 301B 247B 232B 214B 215B 217B 216B 229B
↳ YoY growth +1.7% -17.9% -6.2% -7.7% +0.6% +0.7% -0.3% +6.0%
Japan · Segment operating income (JPY) — 104B 105B 94.2B 83.9B 61.2B 67.8B 72.8B 71.7B 73B
OTC And Others · Segment revenue (JPY) — — 24.3B 24.9B 25.2B 23.8B 23.5B — — —
↳ YoY growth +2.4% +1.0% -5.3% -1.4%
OTC And Others · Segment operating income (JPY) — — 4.53B 4.55B 5.08B 4.7B 5.11B — — —
Reported Jun 21, 2017 Jun 20, 2019 Jun 19, 2020 Jun 19, 2020 Jun 18, 2021 Jun 21, 2023 Jun 21, 2023 Jun 13, 2025 Jun 13, 2025 Jun 12, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Eisai Co., Ltd. (ticker 4523), listed in Japan.

Company History

Date Change Detail
May 16, 2025 Acquired Acquired EcoNaviSta, Inc. (EDINET code E38765). Its filings from before the deal are on its own company page, not shown here.

ETFs Holding Eisai Co., Ltd.

ETF Weight in ETF Shares Market value As of
DTAN 0.48% 3,163 $ 105.126K Nov 17, 2026
DFIV 0.04% 277,751 $ 8.98M Nov 12, 2026
DFAI 0.04% 205,753 $ 6.653M Nov 12, 2026
DFSI 0.03% 9,700 $ 313.627K Nov 12, 2026
DFIC 0.02% 111,200 $ 3.595M Nov 12, 2026
DXIV 0.02% 1,400 $ 45.266K Nov 12, 2026
AVDE 0.01% 50,900 $ 1.671M Nov 16, 2026
AVSD 0.01% 1,100 $ 36.11K Nov 16, 2026
DFAX 0.01% 30,400 $ 982.914K Nov 12, 2026